| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/10/1999 | WO1999027906A1 Long acting injectable formulations containing hydrogenated castor oil |
| 06/10/1999 | WO1999027905A1 Compositions for nasal administration |
| 06/10/1999 | WO1999027901A1 Solid preparation for oral hygiene |
| 06/10/1999 | WO1999027899A1 Hair and/or body hygienic product for human beings and animals |
| 06/10/1999 | WO1999027894A1 Topical anti-acne composition |
| 06/10/1999 | WO1999027891A2 Method for producing solvent-free non-crystalline biologically active substances |
| 06/10/1999 | WO1999027801A1 Revitalisation formulation |
| 06/10/1999 | WO1999027798A1 Improved chewing gum formulations including aspartame and sodium bicarbonate |
| 06/10/1999 | WO1999015156B1 Inhibition of crystallization in transdermal devices |
| 06/10/1999 | WO1999012527A3 Dosage form comprising means for changing drug delivery shape |
| 06/10/1999 | WO1999010375A3 Vaccine against hpv |
| 06/10/1999 | WO1999009964A3 Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections |
| 06/10/1999 | WO1999008684A3 Solutions containing azasteroids |
| 06/10/1999 | WO1999004765A3 Pharmaceutical compositions containing an effervescent acid-base couple |
| 06/10/1999 | DE19812413C1 Transdermal therapeutic system for administration of oxybutynin |
| 06/10/1999 | DE19754324A1 Easily prepared oral dosage forms for acid-labile drugs, especially proton pump inhibitors |
| 06/10/1999 | CA2313029A1 Improved method for avoiding the degradation of an active principle |
| 06/10/1999 | CA2312920A1 Prevention and treatment of amyloidogenic disease |
| 06/10/1999 | CA2312900A1 Transdermal delivery of particulate vaccine compositions |
| 06/10/1999 | CA2312778A1 Combined chemo-immunotherapy with liposomal drugs and cytokines |
| 06/10/1999 | CA2312464A1 Oral antioxidant preparation comprising selenium and reduced glutathione |
| 06/10/1999 | CA2312043A1 Mixed lipopeptide micelles for inducing an immune response |
| 06/10/1999 | CA2311930A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances |
| 06/10/1999 | CA2311780A1 Porous hydroxyapatite particles as carriers for drug substances |
| 06/10/1999 | CA2311633A1 Compositions of leukaemia inhibitory factor |
| 06/10/1999 | CA2310826A1 Soft-pellet drug and process for the preparation thereof |
| 06/10/1999 | CA2310718A1 Vaccine compositions for mucosal administration comprising chitosan |
| 06/10/1999 | CA2310492A1 Improved chewing gum formulations including aspartame and sodium bicarbonate |
| 06/09/1999 | EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| 06/09/1999 | EP0920873A2 Stabilized teriparatide solutions |
| 06/09/1999 | EP0920872A1 Use of rosmarinus officinalis for treating various diseases |
| 06/09/1999 | EP0920869A1 Stable aspirin-containing preparations for external use |
| 06/09/1999 | EP0920861A1 Taste masking powders for pharmaceuticals |
| 06/09/1999 | EP0920843A1 Drug delivery system |
| 06/09/1999 | EP0920345A1 Iontophoretic delivery of cell adhesion inhibitors |
| 06/09/1999 | EP0920339A2 Gene delivery system |
| 06/09/1999 | EP0920338A2 Composition for pharmaceutical applications |
| 06/09/1999 | EP0920337A1 Use of inorganic aerogels in pharmacy |
| 06/09/1999 | EP0920329A1 Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets |
| 06/09/1999 | EP0920324A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| 06/09/1999 | EP0920320A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 06/09/1999 | EP0920311A1 Parenteral paclitaxel in a stable non-toxic formulation |
| 06/09/1999 | EP0920304A1 Method for the production of a granulate for hemodialysis |
| 06/09/1999 | EP0920303A1 Process to produce solid homeopathic compositions |
| 06/09/1999 | EP0920302A1 Pharmaceutical aerosol composition |
| 06/09/1999 | EP0920301A1 Therapeutic or hygienic compositions with controlled and prolonged release of the active principle(s), in particular for ophthalmic use |
| 06/09/1999 | EP0838010A4 High pressure gas exchanger |
| 06/09/1999 | EP0808157B1 Medicated tissue paper product |
| 06/09/1999 | EP0799035A4 Emulsion suitable for administering a sphingolipid and use thereof |
| 06/09/1999 | EP0752855B1 Use of fatty acid esters as bioadhesive substances |
| 06/09/1999 | EP0734260B1 Paroxetine tablets and process to prepare them |
| 06/09/1999 | EP0721327B1 Aerosol composition for forming a preferably hydrated membrane, preferably hydrated membrane so obtained, and applications thereofparticularly as a dressing |
| 06/09/1999 | EP0713390B1 Gelatin capsules containing a highly concentrated acetaminophen solution |
| 06/09/1999 | EP0630232B1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 06/09/1999 | EP0620740B1 Injectable lecithin gel |
| 06/09/1999 | EP0618795B1 Preparations containing a fluorocarbon emulsion and usable as cosmetics or dermatics |
| 06/09/1999 | CN1219132A Sustained-release prostaglandin I derivative preparation |
| 06/09/1999 | CN1219126A Transdermal therampeutic system with small application-area thickness and great flexibility,and production process |
| 06/09/1999 | CN1218692A Novel Anti-spasmodic composition and process for manufacture thereof |
| 06/09/1999 | CN1218689A Chinese drug preparation for curing hepatopathy and its preparation |
| 06/09/1999 | CN1218684A Capsule for expelling stone |
| 06/09/1999 | CN1218680A Liquid for curing scald and burn and its preparing method |
| 06/09/1999 | CN1218677A Bone activating and muscle strengthening pill |
| 06/09/1999 | CN1218672A Compound arnebia root paste for curing heat injury of human body and its preparing method |
| 06/09/1999 | CN1218667A Xinxuezhi capsule for angiocardiopathy and its preparation |
| 06/09/1999 | CN1218664A Method for preparing butethanol of injection |
| 06/08/1999 | US5910512 Capsaicin, magnesium oxide, disodium edta and water; no harsh solvents, gentle to skin; treating rheumatoid arthritis, muscle pain |
| 06/08/1999 | US5910511 Alternative to aspirin which has lesser undesirable side effects |
| 06/08/1999 | US5910510 Administering a photoactive absorber, e.g. a porphyrin, and waiting to have it localize in ocular tissue; radiating with laser light; macular degeneration; treating neovascularization |
| 06/08/1999 | US5910492 Osteogenic promoting pharmaceutical composition |
| 06/08/1999 | US5910489 Treating skin diseases such as cancer, liver spots, genital warts, by topically applying a penetrating formulation of hyaluronic acid and/or salts and an agent to treat the skin such as a nonsteroidal antiinflammatory drug |
| 06/08/1999 | US5910487 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/08/1999 | US5910322 Delayed release pharmaceutical formulation containing amoxycillin and potassium clavulanate |
| 06/08/1999 | US5910321 Multiple flow path device for oral delivery of discrete units |
| 06/08/1999 | US5910320 Tablet or capsule having a content of stable ranitidine hydrochloride form 1 |
| 06/08/1999 | US5910319 Superior single dose formulation of the antidepressant drug, layer comprising hydroxypropylmethylcellulose acetate succinates |
| 06/08/1999 | US5910317 Mixed compositions for treating hypercholesterolemia |
| 06/08/1999 | US5910306 Transdermal delivery system for antigen |
| 06/08/1999 | US5910301 Method of intrapulmonary administration of a narcotic drug |
| 06/08/1999 | CA2151012C Surfactantless water-in-oil emulsion |
| 06/08/1999 | CA2136946C Oral decongestant product |
| 06/03/1999 | WO1999027167A1 Process for the production of protein fibres and products thereof |
| 06/03/1999 | WO1999027071A1 Preservation of sensitive biological samples by vitrification |
| 06/03/1999 | WO1999026971A1 Antimicrobial peptides |
| 06/03/1999 | WO1999026652A1 Mucosal delivery system comprising lipophilic thrombin inhibitors |
| 06/03/1999 | WO1999026636A1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 06/03/1999 | WO1999026635A1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 06/03/1999 | WO1999026631A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 06/03/1999 | WO1999026629A1 Ep2-receptor agonists as neuroprotective agents for the eye |
| 06/03/1999 | WO1999026626A1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions |
| 06/03/1999 | WO1999026625A1 Formulations comprising dissolved paroxetine |
| 06/03/1999 | WO1999026618A1 Skin protection composition |
| 06/03/1999 | WO1999026617A1 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 06/03/1999 | WO1999026608A1 Spheroids, preparation method and pharmaceutical compositions |
| 06/03/1999 | WO1999026607A1 Drug delivery systems utilizing crystal structures |
| 06/03/1999 | WO1999026606A2 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS |
| 06/03/1999 | WO1999026605A1 Conditioning of bioactive glass surfaces in protein containing solutions |
| 06/03/1999 | WO1999026604A2 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 06/03/1999 | WO1999026585A1 Washing composition |
| 06/03/1999 | WO1999026572A1 Antioxidant composition for topical/transdermal prevention and treatment of wrinkles |